Director of Marketing, Diagnostics Lucent Diagnostics

Director Of Marketing, Diagnostics — Lucent Diagnostics

Billerica, MA - Hybrid
Quanterix is a global leader in ultra-sensitive biomarker detection, enabling breakthroughs in disease research, diagnostics, and drug development. Its proprietary Simoa® technology delivers industry-leading sensitivity, allowing researchers to detect and quantify biomarkers in blood and other fluids at concentrations far below traditional limits. With more than 3,400 peer-reviewed publications, Quanterix has been a trusted partner to the scientific community for nearly two decades. In 2025, Quanterix acquired Akoya Biosciences, The Spatial Biology Company®, adding multiplexed tissue imaging with single-cell resolution to its portfolio. Together, the combined company offers a uniquely integrated platform that connects biology across blood and tissue—advancing precision medicine from discovery to diagnostics.
Role Summary

The Director of Marketing, Diagnostics at Lucent Diagnostics, a Quanterix Brand, will play a critical role in developing and executing the marketing strategy for Lucent Diagnostics diagnostic product(s) in advance of and following 510(k) FDA approval. This role requires deep expertise in both clinical marketing and payer marketing, with the ability to bridge scientific, clinical, and economic value propositions. The ideal candidate is a strategic marketer who can operate effectively in a pre-commercial, first-mover environment, influence cross-functional stakeholders across Lucent Diagnostics and Quanterix and build foundational marketing and market development programs that will scale post-approval. A key part of this role is driving early testing adoption and market activation to accelerate awareness, engagement, and uptake ahead of launch. This role will be instrumental in defining product positioning, shaping category and market development strategy, developing market access and reimbursement approaches, and preparing the organization for successful launch and early customer adoption. The Director will partner closely with commercial leadership to help establish brand presence, generate market demand, and position Lucent Diagnostics as a thought leader within an emerging diagnostic category.
What You'll Do

Strategy & Positioning
Lead the development of the overall diagnostic marketing and market development strategy for Lucent in support of test commercialization, medical affairs, market access, and preparation for and following 510(k) clearance
Define and refine product positioning, messaging, and value propositions for key audiences, including clinicians, lab directors, health systems, and payers
Help shape and develop a new diagnostic category by identifying unmet needs, adoption barriers, and opportunities to accelerate market awareness and acceptance
Conduct and synthesize market insights to inform strategic decision-making, including competitive landscape, unmet needs, and adoption drivers
Ensure alignment between LucentDx product strategy and broader Quanterix corporate and platform messaging where appropriate
Partner closely with commercial leadership to align marketing strategy with go-to-market priorities and early customer engagement efforts
Clinical Marketing
Develop and execute clinical marketing strategies that drive awareness, education, and adoption among healthcare providers and laboratory professionals
Collaborate with Medical Affairs, Clinical, and R&D teams across LucentDx and Quanterix to translate clinical evidence into compelling marketing narratives
Create and oversee development of clinical marketing materials, including scientific messaging, educational resources, and presentation content
Support key opinion leader (KOL) engagement, advisory boards, and thought leadership initiatives that advance clinical credibility and category adoption
Lead initiatives to drive early testing adoption, accelerate clinical uptake, and activate target markets prior to full commercialization
Payer & Market Access Marketing
Partner with Market Access and Reimbursement teams to develop payer-focused value propositions and economic messaging
Help shape reimbursement strategy by providing marketing perspective on coverage, coding, and payment considerations
Develop payer marketing materials such as value dossiers, budget impact tools, and executive summaries tailored to health plans and integrated delivery networks
Support market development initiatives that reinforce economic value and facilitate early coverage and adoption
Launch Readiness & Commercial Enablement
Contribute to launch planning and cross-functional commercialization efforts, including pricing, reimbursement, demand generation, and sales enablement
Partner with commercial leadership to support early customer adoption strategies, pilot programs, and initial market penetration
Leverage direct experience driving early adoption and market activation to generate awareness, engagement, and initial uptake ahead of launch
Develop marketing playbooks, training materials, and resources for sales and customer-facing teams
Work closely with Product Management, Sales, Medical Affairs, Regulatory, and Corporate Marketing across Lucent Diagnostics and Quanterix to ensure aligned messaging and execution
Brand, Demand Generation & Thought Leadership
Establish and steward the Lucent diagnostic product brand in alignment with the Quanterix corporate brand and platform narrative
Own development of integrated marketing programs spanning brand strategy, demand generation, and thought leadership initiatives
Drive market awareness through scientific communication, digital engagement, conference strategy, and educational campaigns
Ensure consistency of messaging across marketing channels and customer touchpoints while building long-term brand credibility in a developing market category
Basic Qualifications

Bachelor's degree in marketing, science, or business administration
8+ years of marketing experience in diagnostics, life sciences, or medical devices
Demonstrated experience in both clinical marketing and payer/market access marketing for diagnostic products
Proven track record driving early testing adoption and market activation to accelerate awareness and uptake
Experience working in a pre-commercial, early-stage, or category-creating company environment preferred
Strong understanding of the U.S. healthcare landscape, including reimbursement pathways for diagnostics
Experience preparing for or supporting product launch in regulated markets (e.g., 510(k) or similar).
Preferred Qualifications

Advanced degree (MBA, MPH, PhD, or relevant scientific background)
Experience with novel or disruptive diagnostic technologies
Prior experience of collaborating with Regulatory and Medical Affairs teams
Experience leading market development or category creation initiatives
Expectations, Competencies, Skills & Abilities

Strategic thinker with the ability to operate in ambiguity and build markets from the ground up.
Excellent cross-functional collaborator and influencer across multiple organizations (Lucent Diagnostics and Quanterix)
Strong written and verbal communication skills, with the ability to translate complex science into clear, compelling messaging
Ability to balance scientific rigor with commercial practicality
Demonstrated ability to partner effectively with commercial leadership and support early market adoption.
Comfortable working in a fast-paced, evolving environment
Why You'll Like Working With Us

Why Join Lucent Diagnostics, a Quanterix brand? This is a unique opportunity to help shape the commercial foundation of a transformative diagnostic technology at a pivotal moment in Lucent's journey, while being backed by Quanterix's established leadership in ultra-sensitive diagnostics. You will play a key role in defining how this product category is introduced, positioned, valued, and adopted across the healthcare system. Our Technology : From discovery to diagnostics, Quanterix's ultrasensitive biomarker detection is fueling breakthroughs only made possible through its unparalleled sensitivity and flexibility. Simoa® technology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the Level of Quantification (LoQ). Our industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology, and infectious disease. Akoya Biosciences, a Quanterix company, is The Spatial Biology Company®—bringing tissue context to life through high-resolution, single-cell imaging. Akoya's spatial phenotyping platforms help researchers visualize and measure how cells organize and interact within tissue to influence disease progression and therapeutic response. From discovery through clinical research, Akoya offers a full continuum of solutions, including PhenoCycler®, PhenoImager® Fusion and HT, and PhenoCode™ Panels. As part of Quanterix, Akoya complements a leading portfolio of ultra-sensitive biomarker detection technologies, together enabling a more complete view of biology and disease across both tissue and blood.
Our Commitment to Employees:

At Quanterix, our values are based on: Team, Innovation, Customer and Owner. Team : Challenge assumptions, not the person. Respect diversity of thought and hold